世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医療機器としてのソフトウェアの世界市場規模調査&予測、デバイスタイプ別(スマートフォン、ラップトップ/デスクトップ、ウェアラブルデバイス)、ソフトウェア技術別(人工知能、機械学習)、アプリケーション別(スクリーニングと診断、モニタリングとアラート、慢性疾患と疾病管理、デジタル治療)、地域分析、2022-2029年


Global Software as a Medical Device Market Size study & Forecast, by Device Type (Smartphones, Laptops/Desktops, Wearable Devices) by Software Technology (Artificial Intelligence, Machine Learning), by Application (Screening and Diagnosis, Monitoring and Alerting, Chronic Condition & Disease Management, Digital Therapeutics) and Regional Analysis, 2022-2029

医療機器としてのソフトウェア世界市場は、2021年に約○○億米ドルと評価され、予測期間2022-2029年にはXX%以上の健全な成長率で成長すると予測されています。医療機器としてのソフトウェアには、ソフトウェアベー... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング
2023年5月5日 US$4,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
200 英語

 

サマリー

医療機器としてのソフトウェア世界市場は、2021年に約○○億米ドルと評価され、予測期間2022-2029年にはXX%以上の健全な成長率で成長すると予測されています。医療機器としてのソフトウェアには、ソフトウェアベースの技術を医療目的で使用することが含まれます。SaMDは、病気の診断、治療、予防、または病状のモニタリングに使用されるソフトウェアを指します。これらのソフトウェア製品は、スマートフォン、タブレット、デスクトップコンピューターなど、さまざまなプラットフォーム上で動作します。医療機器としてのソフトウェア市場の主な推進要因は、リモートヘルスケアに対する需要の高まりと慢性疾患の有病率の増加です。さらに、技術の進歩や主要な市場プレイヤーのイニシアティブの高まりが、予測期間2022年から2029年にかけて、市場に有利な成長機会を生み出しています。

2019年、遠隔医療企業Teladocは、遠隔医療サービスに対する需要の高まりを反映し、仮想訪問量が前年比80%増加したことを報告しました。2021年、アクセンチュアの調査によると、米国では前年と比較して60%の患者がデジタルヘルスツールの利用に積極的であると回答し、91%の回答者が医療従事者から勧められたらデジタルヘルスツールを利用すると答えています。2022年2月には、米国保健福祉省が遠隔医療サービスに対するメディケアの適用範囲を拡大すると発表しており、遠隔医療サービスに対する需要の高まりが反映されています。しかし、医療機器としてのソフトウェアのコストが高いため、2022年から2029年の予測期間を通じて、市場の成長が阻害されます。

医療機器としてのソフトウェア市場の調査対象地域は、アジア太平洋地域、北米、欧州、中南米、およびその他の地域です。北米、特に米国は、確立された医療制度、デジタルヘルス技術の採用の増加、SaMDに対する良好な規制環境のため、現在SaMDの最大市場となっています。また、アジア太平洋地域は、医療費の増加、患者数の増加、高度な医療技術への需要の高まりにより、SaMD市場が大きく成長しています。日本、中国、インドは、この地域の主要な市場の一部です。

本レポートに含まれる主な市場関係者は以下の通りです:
GEヘルスケア - 米国
iCAD Inc.・・・米国
ハイパーファインリサーチ - 米国
スター - 米国
Tietronix Software, Inc.
S3 Connected Health - アイルランド
Ideagen - イギリス
BrightInsight, Inc.
Inzentiz - ドイツ
Zühlke Group - スイス

市場における最近の動き
 国際的なテクノロジー企業であるStarは、2021年7月にMedTechソリューションの大手プロバイダーであるPro 4 Peopleを買収したことを明らかにした。買収により、Starの既存の製品ラインは拡大された。
 S3 Connected Healthとのコラボレーションで、FutureNeuroは2019年8月にてんかん治療のための共同設計手法を取り入れた。
世界の医療機器としてのソフトウェア市場レポートスコープ:
過去データ 2019年~2020年~2021年
推計基準年 2021年
予測期間 2022年〜2029年
レポート対象 売上高予測、企業ランキング、競合状況、成長要因、トレンド
対象セグメント デバイスタイプ、ソフトウェア技術、アプリケーション、地域
地域範囲 北米、欧州、アジア太平洋、中南米、その他の地域
カスタマイズ範囲 レポート購入時に無料カスタマイズ(アナリストの作業時間8時間相当まで)。国別、地域別、セグメント別スコープの追加・変更*。

本調査の目的は、近年における様々なセグメントおよび国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国において、業界の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する推進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境とデバイスタイプの提供物の詳細な分析とともに、関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します:
デバイスタイプ別
デバイスタイプ別:スマートフォン
ノートPC/デスクトップPC
ウェアラブルデバイス
ソフトウェア技術別
人工知能(Artificial Intelligence
機械学習
アプリケーション別
スクリーニング・診断
モニタリングとアラート
慢性疾患・疾病管理
デジタル・セラピューティクス

地域別
北米
米国
カナダ
欧州
英国
ドイツ
フランス
スペイン
イタリア
ROE
アジア・パシフィック
中国
インド
日本
オーストラリア
韓国
ロアパック
ラテンアメリカ
ブラジル
メキシコ
その他の地域

ページTOPに戻る


目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Software as a Medical Device Market, by region, 2019-2029 (USD Billion)
1.2.2. Software as a Medical Device Market, by Device Type, 2019-2029 (USD Billion)
1.2.3. Software as a Medical Device Market, by Software Technology, 2019-2029 (USD Billion)
1.2.4. Software as a Medical Device Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Software as a Medical Device Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Software as a Medical Device Market Dynamics
3.1. Software as a Medical Device Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for remote healthcare
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Software as a Medical Device
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Rising initiatives by the key market players
Chapter 4. Global Software as a Medical Device Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Software as a Medical Device Market, by Device Type
6.1. Market Snapshot
6.2. Global Software as a Medical Device Market by Device Type, Performance - Potential Analysis
6.3. Global Software as a Medical Device Market Estimates & Forecasts by Device Type 2019-2029 (USD Billion)
6.4. Software as a Medical Device Market, Sub Segment Analysis
6.4.1. Smartphones
6.4.2. Laptops/Desktops
6.4.3. Wearable Devices
Chapter 7. Global Software as a Medical Device Market, by Software Technology
7.1. Market Snapshot
7.2. Global Software as a Medical Device Market by Software Technology, Performance - Potential Analysis
7.3. Global Software as a Medical Device Market Estimates & Forecasts by Software Technology 2019-2029 (USD Billion)
7.4. Software as a Medical Device Market, Sub Segment Analysis
7.4.1. Artificial Intelligence
7.4.2. Machine Learning
Chapter 8. Global Software as a Medical Device Market, by Application
8.1. Market Snapshot
8.2. Global Software as a Medical Device Market by Application, Performance - Potential Analysis
8.3. Global Software as a Medical Device Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Software as a Medical Device Market, Sub Segment Analysis
8.4.1. Screening and Diagnosis
8.4.2. Monitoring and Alerting
8.4.3. Chronic Condition & Disease Management
8.4.4. Digital Therapeutics
Chapter 9. Global Software as a Medical Device Market, Regional Analysis
9.1. Software as a Medical Device Market, Regional Market Snapshot
9.2. North America Software as a Medical Device Market
9.2.1. U.S. Software as a Medical Device Market
9.2.1.1. Device Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Software Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. Application breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Software as a Medical Device Market
9.3. Europe Software as a Medical Device Market Snapshot
9.3.1. U.K. Software as a Medical Device Market
9.3.2. Germany Software as a Medical Device Market
9.3.3. France Software as a Medical Device Market
9.3.4. Spain Software as a Medical Device Market
9.3.5. Italy Software as a Medical Device Market
9.3.6. Rest of Europe Software as a Medical Device Market
9.4. Asia-Pacific Software as a Medical Device Market Snapshot
9.4.1. China Software as a Medical Device Market
9.4.2. India Software as a Medical Device Market
9.4.3. Japan Software as a Medical Device Market
9.4.4. Australia Software as a Medical Device Market
9.4.5. South Korea Software as a Medical Device Market
9.4.6. Rest of Asia Pacific Software as a Medical Device Market
9.5. Latin America Software as a Medical Device Market Snapshot
9.5.1. Brazil Software as a Medical Device Market
9.5.2. Mexico Software as a Medical Device Market
9.6. Rest of The World Software as a Medical Device Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. GE Healthcare- United States
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. iCAD Inc. - United States
10.2.3. Hyperfine Research - United States
10.2.4. Star - United States
10.2.5. Tietronix Software, Inc. - United States
10.2.6. S3 Connected Health - Ireland
10.2.7. Ideagen - United Kingdom
10.2.8. BrightInsight, Inc. - United States
10.2.9. Inzentiz - Germany
10.2.10. Zühlke Group - Switzerland
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

 

ページTOPに戻る


 

Summary

Global Software as a Medical Device Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Software as Medical Devices involves the use of software-based technologies for medical purposes. SaMD refers to software that are used in the diagnosis, treatment, or prevention of disease, or in the monitoring of medical conditions. These software products can run on various platforms, such as smartphones, tablets, or desktop computers. The major driving factors for the Global Software as a Medical Device Market are increasing demand for remote healthcare and growing prevalence of chronic diseases. Moreover, technological advancements and rising initiatives the key market players are creating lucrative growth opportunity for the market over the forecast period 2022-2029.

In 2019, the telemedicine company Teladoc reported that its virtual visit volume had increased by 80% compared to the previous year, reflecting the growing demand for remote healthcare services. In 2021, a survey by Accenture found that 60% of patients in the United States reported being more willing to use digital health tools compared to the previous year, with 91% of respondents saying they would use digital health tools if they were recommended by their healthcare provider. In February 2022, the US Department of Health and Human Services announced that it would be extending Medicare coverage for telehealth services, reflecting the ongoing demand for remote healthcare services. However, the high cost of Software as a Medical Device stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Software as a Medical Device Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America, particularly the United States, is currently the largest market for SaMD due to the well-established healthcare system, increasing adoption of digital health technologies, and favorable regulatory environment for SaMD. The Asia-Pacific region is also seeing significant growth in the SaMD market due to the increasing healthcare expenditure, large patient population, and growing demand for advanced healthcare technologies. Japan, China, and India are some of the key markets in this region.

Major market player included in this report are:
GE Healthcare - United States
iCAD Inc. - United States
Hyperfine Research - United States
Star - United States
Tietronix Software, Inc. - United States
S3 Connected Health - Ireland
Ideagen - United Kingdom
BrightInsight, Inc. - United States
Inzentiz - Germany
Zühlke Group – Switzerland

Recent Developments in the Market:
 An international technology corporation called Star revealed in July 2021 that it has acquired Pro 4 People, a major provider of MedTech solutions. Star's existing product line was expanded owing to the acquisition.
 In a collaboration with S3 Connected Health, FutureNeuro embraced the co-design methodology for the treatment of epilepsy in August 2019.
Global Software as a Medical Device Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Device Type, Software Technology, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Device Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device Type:
Smartphones
Laptops/Desktops
Wearable Devices
By Software Technology:
Artificial Intelligence
Machine Learning
By Application:
Screening and Diagnosis
Monitoring and Alerting
Chronic Condition & Disease Management
Digital Therapeutics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World



ページTOPに戻る


Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Software as a Medical Device Market, by region, 2019-2029 (USD Billion)
1.2.2. Software as a Medical Device Market, by Device Type, 2019-2029 (USD Billion)
1.2.3. Software as a Medical Device Market, by Software Technology, 2019-2029 (USD Billion)
1.2.4. Software as a Medical Device Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Software as a Medical Device Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Software as a Medical Device Market Dynamics
3.1. Software as a Medical Device Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for remote healthcare
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Software as a Medical Device
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Rising initiatives by the key market players
Chapter 4. Global Software as a Medical Device Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Software as a Medical Device Market, by Device Type
6.1. Market Snapshot
6.2. Global Software as a Medical Device Market by Device Type, Performance - Potential Analysis
6.3. Global Software as a Medical Device Market Estimates & Forecasts by Device Type 2019-2029 (USD Billion)
6.4. Software as a Medical Device Market, Sub Segment Analysis
6.4.1. Smartphones
6.4.2. Laptops/Desktops
6.4.3. Wearable Devices
Chapter 7. Global Software as a Medical Device Market, by Software Technology
7.1. Market Snapshot
7.2. Global Software as a Medical Device Market by Software Technology, Performance - Potential Analysis
7.3. Global Software as a Medical Device Market Estimates & Forecasts by Software Technology 2019-2029 (USD Billion)
7.4. Software as a Medical Device Market, Sub Segment Analysis
7.4.1. Artificial Intelligence
7.4.2. Machine Learning
Chapter 8. Global Software as a Medical Device Market, by Application
8.1. Market Snapshot
8.2. Global Software as a Medical Device Market by Application, Performance - Potential Analysis
8.3. Global Software as a Medical Device Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Software as a Medical Device Market, Sub Segment Analysis
8.4.1. Screening and Diagnosis
8.4.2. Monitoring and Alerting
8.4.3. Chronic Condition & Disease Management
8.4.4. Digital Therapeutics
Chapter 9. Global Software as a Medical Device Market, Regional Analysis
9.1. Software as a Medical Device Market, Regional Market Snapshot
9.2. North America Software as a Medical Device Market
9.2.1. U.S. Software as a Medical Device Market
9.2.1.1. Device Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Software Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. Application breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Software as a Medical Device Market
9.3. Europe Software as a Medical Device Market Snapshot
9.3.1. U.K. Software as a Medical Device Market
9.3.2. Germany Software as a Medical Device Market
9.3.3. France Software as a Medical Device Market
9.3.4. Spain Software as a Medical Device Market
9.3.5. Italy Software as a Medical Device Market
9.3.6. Rest of Europe Software as a Medical Device Market
9.4. Asia-Pacific Software as a Medical Device Market Snapshot
9.4.1. China Software as a Medical Device Market
9.4.2. India Software as a Medical Device Market
9.4.3. Japan Software as a Medical Device Market
9.4.4. Australia Software as a Medical Device Market
9.4.5. South Korea Software as a Medical Device Market
9.4.6. Rest of Asia Pacific Software as a Medical Device Market
9.5. Latin America Software as a Medical Device Market Snapshot
9.5.1. Brazil Software as a Medical Device Market
9.5.2. Mexico Software as a Medical Device Market
9.6. Rest of The World Software as a Medical Device Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. GE Healthcare- United States
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. iCAD Inc. - United States
10.2.3. Hyperfine Research - United States
10.2.4. Star - United States
10.2.5. Tietronix Software, Inc. - United States
10.2.6. S3 Connected Health - Ireland
10.2.7. Ideagen - United Kingdom
10.2.8. BrightInsight, Inc. - United States
10.2.9. Inzentiz - Germany
10.2.10. Zühlke Group - Switzerland
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療IT)の最新刊レポート

Bizwit Research & Consulting LLP社のヘルスケアIT分野での最新刊レポート

本レポートと同じKEY WORD(as)の最新刊レポート


よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る